Speaker Profile
Ph.D., CEO, Gero.AI
Biography
Peter was top-2 cited Russian physicist under 35 before he switched to biotech 15 years ago. In 2015, he co-founded Gero, AI-driven longevity startup focused on developing therapies that will extend a healthy human lifespan. He continues his studies in the field of aging biology and biophysics serving as Gero Chief Science Officer and currently has more than 70 papers published in peer-reviewed journals.
Wellness and Aging Showcase:
Gero.AI
Gero is an AI-driven drug discovery company focused on therapies targeting aging and age-related diseases.
GERO AI: Drug Discovery Against Complex Diseases
Gero has developed a platform for targets and biomarkers of aging identification. Recently Gero demonstrated outstanding results rejuvenating mice and extending their maximum lifespan in the lab of one of the top researchers in the field - Brian Kennedy.
Session Abstract – PMWC 2020 Silicon Valley
The PMWC 2020 Wellness & Aging Showcase will provide a 15-minute time slot for selected companies in Wellness and Aging to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from selected companies that build innovative solutions and harness the power of digital health, genomics, and data science with the goal to proactively prevent disease, maintain optimal health, and slow down aging.
